TipRanks
pc:con05

Convergen

https://www.converge-bio.com/
Convergen is a biotech company pioneering TrimTAC—next-generation bifunctional degraders that leverage TRIM21 to selectively clear pathological multimeric proteins. Founded to address unmet medical needs in neurodegenerative disease and beyond, the company combines cutting-edge academic research with industry-proven drug development expertise to advance therapies for significantly unmet medical needs.

Leadership & Board

Current Number of Employees54
Current LinkedIn Followers6,623

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$25M
Total Amount Raised$25M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$15M
Latest Funding Amount$15M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Company Momentum Positive

Articles Published on TipRanks1
Articles Published on TipRanks
1
LinkedIn Trend+2.40% followers
LinkedIn Trend
+2.40% followers
Workforce Trend+0.0% employees
Workforce Trend
+0.0% employees
Convergen LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.

Employee Trend

Convergen had 54 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
54Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Convergen had 6,623 followers as of September 14, 2026. The number of followers increased by 155 (2.40%) week-over-week.
6,623Latest Followers Count
155(2.40%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 31, 2026
Seed Round
$15.00M
Dec 08, 2025
Seed Round
$10.00M

Investors

Investor Name
Funding Round
Seed Round
Seed Round

Similar Companies

A snapshot of private companies similar to Convergen, helping you discover and navigate related company profiles.

Related News and Analysis